アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

nv organon - vecuronium bromide - pdr+solv for soln for inj - 10 milligram

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - rocuronium bromide, quantity: 100 mg - injection, solution - excipient ingredients: acetic acid; sodium hydroxide; sodium chloride; water for injections; sodium acetate trihydrate - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - rocuronium bromide, quantity: 50 mg - injection, solution - excipient ingredients: sodium hydroxide; acetic acid; water for injections; sodium acetate trihydrate; sodium chloride - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc) - l-methylfolate calcium tablets are labeled as a medical food for the distinct nutritional requirements of individuals who have or are at risk for hyperhomocysteinemia and other conditions relating to suboptimal l-methylfolate levels. l-methylfolate calcium is contraindicated in patients with known hypersensitivity to any of the components contained in this product. folic acid, when administered in daily doses above 0.1 mg, may obscure the detection of b12 deficiency (specifically, the administration of folic acid may reverse the hematological manifestations of b12 deficiency, including pernicious anemia, while not addressing the neurological manifestations). l-methylfolate may be less likely than folic acid to mask vitamin b12 deficiency.2,3 folate therapy alone is inadequate for the treatment of a b12 deficiency. l-methylfolate calcium is a medical food1 for use under the medical supervision of a physician or health-care provider. before using this product, tell your doctor or pharmacist of all the products you use. keep a list of all your medications with you, and share the list with your doctor and pharmacist. no decrease in effectiveness of drugs has been reported with the use of l-methylfolate calcium. l-methylfolate calcium contains folate, which may have interactions with the following: - antiepileptic drugs (aed): the aed class including, but not limited to, phenytoin, carbamazepine, primidone, valproic acid, phenobarbital and lamotrigine have been shown to impair folate absorption and increase the metabolism of circulating folate. additionally concurrent use of folic acid has been associated with enhanced phenytoin metabolism, lowering the level of this aed in the blood and allowing break through seizures to occur.4,5,7,10 - capecitabine: folinic acid (5-formyltetrahydrofolate) may increase the toxicity of capecitabine.6 - dihydrofolate reductase inhibitors (dhfri): dhfris block the conversion of folic acid to its active forms, and lower plasma and red blood cell folate levels. dhfirs include aminopterin, methotrexate, pyrimethamine, triamterene, and trimethoprim.7 - fluoxetine: fluoxetine exerts a non-competitive inhibition of the 5-methyltetrahydrofolate active transport in the intestine.8 - isotretinoin: reduced folate levels have occurred in some patients taking isotretinoin.9 - nonsteroidal anti-inflammatory drugs (nsaids): nsaids have been shown to inhibit some folate dependent enzymes in laboratory experiments nsaids include ibuprofen, naproxen, indomethacin and sulindac.7 - oral contraceptives: serum folate levels may be depressed by oral contraceptive therapy.7 - methylprednisolone: reduced serum folate levels have been noted after treatment with methylprednisolone.7 - pancreatic enzymes: reduced folate levels have occurred in some patients taking pancreatic extracts.7 - pentamidine: reduced folate levels have been seen with prolonged intravenous pentamidine.7 - metformin treatment in patients with type 2 diabetes decreases serum folate.11,12 - warfarin can produce significant impairment in folate status after a 6-month therapy.13

マルタ - 英語 - Medicines Authority

adelco-chromatourgia anthinon e. colocotronis bros s.a. 37 pireos str, 183 46, moschato, athens, greece - folic acid - tablet - folic acid 5 mg - antianemic preparations

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

virtus pharmaceuticals - pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), anhydrous dibasic calcium phosphate (unii: l11k75p92j) (anhydrous dibasic calcium phosphate - unii:l11k75p92j), tricalcium phosphate (unii: k4c08xp666) (calcium cation - unii:2m83c4r6zb), ginger (unii: c5529g5jpq) (ginger - unii:c5529g5jpq) - pyridoxine hydrochloride 40 mg - indications and usage: vp-ggr-b6 is indicated for the distinct nutritional requirements of patients in need of prenatal dietary supplementation as determined by a licensed medical practitioner. vp-ggr-b6 should be administered under the supervision of a licensed medical practitioner. contraindications: this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

nv organon - vecuronium bromide - pdr+solv for soln for inj - 10 milligram

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

hospira pty limited - rocuronium bromide -